Our practice handles U.S. and international transactions involving innovation based enterprises, collaborative relationships for research and the development and commercialization of emerging technologies, and the sale or licensing of IP rights.
Successful IP transactions require both the transactional know how and IP experience. Our team’s experience includes: the drafting and negotiating of letters of intent (LOIs), memoranda of understanding (MOUs), non-disclosure agreements (NDAs), collaborative research agreements, sponsored research agreements, technology commercialization agreements, end-user agreements and a wide variety of patent, trademark and software license agreements.
We work closely with clients who are seeking to commercialize their technology around the world. We help preserve IP rights in other countries in connection with commercialization strategies and help create relationships and opportunities in the US, all while expediting US patent filings in order to assist in establishing a solid foundation for fast-tracking rights in other countries and facilitating commercialization. International agreements must address complex and often highly sensitive issues such as compliance with export and import control laws in the respective countries and determining the best choice of law for governing the agreement.
Our IP team works collaboratively with the firm’s Corporate Practice Group based in New York’s financial district, which includes experienced attorneys who have represented all categories of participants in mergers and acquisitions. We help clients with company formation, finance and growth, and represent clients in all stages of a company’s lifecycle from founders and angel investor transactions to private equity transactions and public offerings.